Gefitinib Completed Phase 2 Trials for Neoplasms, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00052169Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer
NCT00229697Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study